{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:29:20Z","timestamp":1786649360106,"version":"build-2736575974"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:p>\n                    Dravet syndrome (DS) is a developmental epileptic encephalopathy, characterized by fever-triggered focal or hemiclonic seizures at onset with various associated comorbidities like intellectual disability, gait abnormalities, and behavioral issues. It typically advances to drug-refractory epilepsy with multiple seizure semiology. In this review, we give a focused narrative on the treatment aspects of DS. We searched the PubMed database for articles on DS. More than 500 articles were reviewed, of which 55 relevant articles are included in this review. ClinicalTrials.gov database was also accessed for data on ongoing trials. Majority are caused by mutations in the\n                    <jats:italic toggle=\"yes\">SCN1A<\/jats:italic>\n                    gene. Valproate and clobazam are the most commonly used traditional antiseizure medications. Stiripentol, fenfluramine, and cannabidiol are recently approved drugs with promising results. Ketogenic diet and vagus nerve stimulation are commonly tried nonpharmacologic modalities that have shown significant responses. Antisense oligonucleotides and viral vector-mediated gene transfer therapies are on the horizon. This review outlines the current existing treatment rationale, evidence for newly approved drugs, and the future scope of gene therapy in DS.\n                  <\/jats:p>","DOI":"10.4103\/aian.aian_49_24","type":"journal-article","created":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T11:30:06Z","timestamp":1723807806000},"page":"352-357","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Advancements in Dravet Syndrome Therapeutics: A Comprehensive Look at Present and Future Treatment Horizons: A Focused Review"],"prefix":"10.4103","volume":"27","author":[{"given":"Aakash","family":"Mahesan","sequence":"first","affiliation":[{"name":"Centre of Excellence and Advanced Research for Childhood Neurodevelopmental Disorders, Child Neurology Division, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautam","family":"Kamila","sequence":"additional","affiliation":[{"name":"Centre of Excellence and Advanced Research for Childhood Neurodevelopmental Disorders, Child Neurology Division, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheffali","family":"Gulati","sequence":"additional","affiliation":[{"name":"Centre of Excellence and Advanced Research for Childhood Neurodevelopmental Disorders, Child Neurology Division, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,8,16]]},"reference":[{"key":"R1-20260427","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/epi.17239","article-title":"ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: Position statement by the ILAE Task Force on Nosology and Definitions","volume":"63","author":"Zuberi","year":"2022","journal-title":"Epilepsia"},{"key":"R2-20260427","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.yebeh.2017.06.031","article-title":"Dravet syndrome: Characteristics, comorbidities, and caregiver concerns","volume":"74","author":"Villas","year":"2017","journal-title":"Epilepsy Behav"},{"key":"R3-20260427","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1528-1167.2011.02997.x","article-title":"The genetics of Dravet syndrome","volume":"52","author":"Marini","year":"2011","journal-title":"Epilepsia"},{"key":"R4-20260427","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s10545-012-9492-z","article-title":"Natural disease course and genotype\u2010phenotype correlations in Complex I deficiency caused by nuclear gene defects: What we learned from 130 cases","volume":"35","author":"Koene","year":"2012","journal-title":"J Inherit Metab Dis"},{"key":"R5-20260427","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1111\/epi.13889","article-title":"Dravet syndrome and its mimics: Beyond SCN 1A","volume":"58","author":"Steel","year":"2017","journal-title":"Epilepsia"},{"key":"R6-20260427","doi-asserted-by":"crossref","first-page":"e1310","DOI":"10.1542\/peds.2015-1807","article-title":"Incidence of Dravet Syndrome in a US Population","volume":"136","author":"Wu","year":"2015","journal-title":"Pediatrics"},{"key":"R7-20260427","doi-asserted-by":"crossref","first-page":"106922","DOI":"10.1016\/j.eplepsyres.2022.106922","article-title":"Dravet syndrome in children\u2014A population-based study","volume":"182","author":"Bjurulf","year":"2022","journal-title":"Epilepsy Res"},{"key":"R8-20260427","doi-asserted-by":"crossref","first-page":"108442","DOI":"10.1016\/j.yebeh.2021.108442","article-title":"Epidemiology, healthcare resource use, and mortality in patients with probable Dravet syndrome: A population-based study on German health insurance data","volume":"126","author":"Schubert-Bast","year":"2022","journal-title":"Epilepsy Behav"},{"key":"R9-20260427","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1038\/s41598-023-30273-z","article-title":"Patient profile, management, and quality of life associated with Dravet syndrome: A cross-sectional, multicentre study of 80 patients in Spain","volume":"13","author":"Gil-Nagel","year":"2023","journal-title":"Sci Rep"},{"key":"R10-20260427","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1528-1167.2007.01475.x","article-title":"A Screening test for the prediction of Dravet syndrome before one year of age","volume":"49","author":"Hattori","year":"2008","journal-title":"Epilepsia"},{"key":"R11-20260427","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1111\/epi.17274","article-title":"International consensus on diagnosis and management of Dravet syndrome","volume":"63","author":"Wirrell","year":"2022","journal-title":"Epilepsia"},{"key":"R12-20260427","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s40263-022-00898-1","article-title":"A practical guide to the treatment of Dravet syndrome with anti-seizure medication","volume":"36","author":"Strzelczyk","year":"2022","journal-title":"CNS Drugs"},{"key":"R13-20260427","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/dmcn.12593","article-title":"Lamotrigine can be beneficial in patients with Dravet syndrome","volume":"57","author":"Dalic","year":"2015","journal-title":"Dev Med Child Neurol"},{"key":"R14-20260427","doi-asserted-by":"crossref","first-page":"106743","DOI":"10.1016\/j.eplepsyres.2021.106743","article-title":"Dravet syndrome: A quick transition guide for the adult neurologist","volume":"177","author":"Andrade","year":"2021","journal-title":"Epilepsy Res"},{"key":"R15-20260427","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s40263-018-0511-y","article-title":"Treatment strategies for dravet syndrome","volume":"32","author":"Knupp","year":"2018","journal-title":"CNS Drugs"},{"key":"R16-20260427","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3390\/brainsci11010088","article-title":"Congenital disorders of glycosylation from a neurological perspective","volume":"11","author":"Paprocka","year":"2021","journal-title":"Brain Sci"},{"key":"R17-20260427","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.clinph.2016.11.021","article-title":"Photosensitivity in Dravet syndrome is under-recognized and related to prognosis","volume":"128","author":"Verbeek","year":"2017","journal-title":"Clin Neurophysiol"},{"key":"R18-20260427","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1528-1167.2011.03008.x","article-title":"The effects of stiripentol on GABA A receptors","volume":"52","author":"Fisher","year":"2011","journal-title":"Epilepsia"},{"key":"R19-20260427","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(00)03157-3","article-title":"Stiripentol in severe myoclonic epilepsy in infancy: A randomised placebo-controlled syndrome-dedicated trial","volume":"356","author":"Chiron","year":"2000","journal-title":"The Lancet"},{"key":"R20-20260427","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s40265-023-01936-y","article-title":"Pharmacotherapy for Dravet syndrome: A systematic review and network meta-analysis of randomized controlled trials","volume":"83","author":"Lattanzi","year":"2023","journal-title":"Drugs"},{"key":"R21-20260427","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1684\/epd.2020.1135","article-title":"The proposed mechanisms of action of CBD in epilepsy","volume":"22","author":"Gray","year":"2020","journal-title":"Epileptic Disord"},{"key":"R22-20260427","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(18)30136-3","article-title":"Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): A randomised, double-blind, placebo-controlled phase 3 trial","volume":"391","author":"Thiele","year":"2018","journal-title":"The Lancet"},{"key":"R23-20260427","doi-asserted-by":"crossref","first-page":"1192022","DOI":"10.3389\/fphar.2023.1192022","article-title":"Fenfluramine: A plethora of mechanisms?","volume":"14","author":"Sourbron","year":"2023","journal-title":"Front Pharmacol"},{"key":"R24-20260427","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/S0140-6736(19)32500-0","article-title":"Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: A randomised, double-blind, placebo-controlled trial","volume":"394","author":"Lagae","year":"2019","journal-title":"Lancet"},{"key":"R25-20260427","first-page":"CD001903","article-title":"Ketogenic diets for drug-resistant epilepsy","volume":"6","author":"Martin-McGill","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"R26-20260427","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1001\/jamapediatrics.2020.2282","article-title":"Efficacy of ketogenic diet, modified atkins diet, and low glycemic index therapy diet among children with drug-resistant epilepsy: A randomized clinical trial","volume":"174","author":"Sondhi","year":"2020","journal-title":"JAMA Pediatr"},{"key":"R27-20260427","doi-asserted-by":"crossref","first-page":"699","DOI":"10.6061\/clinics\/2014(10)09","article-title":"Neurobiochemical mechanisms of a ketogenic diet in refractory epilepsy","volume":"69","author":"De Lima","year":"2014","journal-title":"Clinics"},{"key":"R28-20260427","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/j.1528-1167.2005.05705.x","article-title":"Ketogenic Diet in patients with Dravet syndrome","volume":"46","author":"Caraballo","year":"2005","journal-title":"Epilepsia"},{"key":"R29-20260427","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.seizure.2020.07.011","article-title":"Efficacy of the ketogenic diet in patients with Dravet syndrome: A meta-analysis","volume":"81","author":"Wang","year":"2020","journal-title":"Seizure"},{"key":"R30-20260427","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.3171\/2011.7.JNS11977","article-title":"Vagus nerve stimulation for epilepsy: A meta-analysis of efficacy and predictors of response: A review","volume":"115","author":"Englot","year":"2011","journal-title":"J Neurosurg"},{"key":"R31-20260427","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4103\/2152-7806.103015","article-title":"Vagus nerve stimulation for epilepsy: A review of central mechanisms","volume":"3","author":"Krahl","year":"2012","journal-title":"Surg Neurol Int"},{"key":"R32-20260427","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.seizure.2017.06.007","article-title":"Efficacy of adjunctive vagus nerve stimulation in patients with Dravet syndrome: A meta-analysis of 68 patients","volume":"50","author":"Dibu\u00e9-Adjei","year":"2017","journal-title":"Seizure"},{"key":"R33-20260427","doi-asserted-by":"crossref","first-page":"106665","DOI":"10.1016\/j.eplepsyres.2021.106665","article-title":"Long-term results of vagus nerve stimulation in children with Dravet syndrome: Time-dependent, delayed antiepileptic effect","volume":"174","author":"Youn","year":"2021","journal-title":"Epilepsy Res"},{"key":"R34-20260427","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1021\/acschemneuro.5b00342","article-title":"Serotonergic modulation as effective treatment for Dravet syndrome in a Zebrafish mutant model","volume":"7","author":"Sourbron","year":"2016","journal-title":"ACS Chem Neurosci"},{"key":"R35-20260427","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0068-15.2015","article-title":"Large-scale phenotype-based antiepileptic drug screening in a Zebrafish model of Dravet syndrome","volume":"2","author":"Dinday","year":"2015","journal-title":"eNeuro"},{"key":"R36-20260427","first-page":"669","article-title":"Clemizole and modulators of serotonin signalling suppress seizures in Dravet syndrome","volume":"140","author":"Griffin","year":"2017","journal-title":"Brain"},{"key":"R37-20260427","doi-asserted-by":"crossref","first-page":"107417","DOI":"10.1016\/j.pharmthera.2019.107417","article-title":"Lorcaserin: A review of its preclinical and clinical pharmacology and therapeutic potential","volume":"205","author":"Higgins","year":"2020","journal-title":"Pharmacol Ther"},{"key":"R38-20260427","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1212\/WNL.0000000000006432","article-title":"Lorcaserin therapy for severe epilepsy of childhood onset: A case series","volume":"91","author":"Tolete","year":"2018","journal-title":"Neurology"},{"key":"R39-20260427","doi-asserted-by":"crossref","first-page":"e13170","DOI":"10.1111\/obr.13170","article-title":"Is lorcaserin really associated with increased risk of cancer? A systematic review and meta\u2010analysis","volume":"22","author":"De Andrade Mesquita","year":"2021","journal-title":"Obes Rev"},{"key":"R40-20260427","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1017\/S1092852900024020","article-title":"Mechanism of Action of Trazodone: A multifunctional drug","volume":"14","author":"Stahl","year":"2009","journal-title":"CNS Spectr"},{"key":"R41-20260427","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/epi4.12604","article-title":"Clemizole and trazodone are effective antiseizure treatments in a zebrafish model of STXBP1 disorder","volume":"7","author":"Moog","year":"2022","journal-title":"Epilepsia Open"},{"key":"R42-20260427","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1055\/s-0039-1677783","article-title":"Trazodone: A new antiepileptic drug for Dravet syndrome?","volume":"5","author":"Azevedo Kauppila","year":"2018","journal-title":"Int J Epilepsy"},{"issue":"18_supplement","key":"R43-20260427","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1212\/WNL.98.18_supplement.1771","article-title":"A randomized, double-blind, placebo-controlled, multiple ascending dose Pharmacokinetics (PK), Pharmacodynamics (PD), and tolerability of LP352 in healthy subjects (P14-8.002)","volume":"98","author":"Parasrampuria","year":"2022","journal-title":"Neurology"},{"key":"R44-20260427","doi-asserted-by":"crossref","first-page":"17081","DOI":"10.1038\/s41598-020-74036-6","article-title":"Soticlestat, a novel cholesterol 24-hydroxylase inhibitor shows a therapeutic potential for neural hyperexcitation in mice","volume":"10","author":"Nishi","year":"2020","journal-title":"Sci Rep"},{"key":"R45-20260427","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.1111\/bcp.14854","article-title":"Safety, tolerability, pharmacokinetics, pharmacodynamics, bioavailability and food effect of single doses of soticlestat in healthy subjects","volume":"87","author":"Wang","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"R46-20260427","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1111\/epi.17367","article-title":"A phase 2, randomized, double\u2010blind, placebo\u2010controlled study to evaluate the efficacy and safety of soticlestat as adjunctive therapy in pediatric patients with Dravet syndrome or Lennox\u2013Gastaut syndrome (ELEKTRA)","volume":"63","author":"Hahn","year":"2022","journal-title":"Epilepsia"},{"key":"R48-20260427","doi-asserted-by":"crossref","first-page":"12353","DOI":"10.1073\/pnas.1615548113","article-title":"Proposing a mechanism of action for ataluren","volume":"113","author":"Siddiqui","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"R49-20260427","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/acn3.51306","article-title":"Ataluren for drug\u2010resistant epilepsy in nonsense variant\u2010mediated Dravet syndrome and CDKL5 deficiency disorder","volume":"8","author":"Devinsky","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"R51-20260427","doi-asserted-by":"crossref","first-page":"106193","DOI":"10.1016\/j.nbd.2023.106193","article-title":"A novel rat model of Dravet syndrome recapitulates clinical hallmarks","volume":"184","author":"Li","year":"2023","journal-title":"Neurobiol Dis"},{"key":"R52-20260427","doi-asserted-by":"crossref","first-page":"eaaz6100","DOI":"10.1126\/scitranslmed.aaz6100","article-title":"Antisense oligonucleotides increase Scn1a expression and reduce seizures and SUDEP incidence in a mouse model of Dravet syndrome","volume":"12","author":"Han","year":"2020","journal-title":"Sci Transl Med"},{"key":"R53-20260427","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ebiom.2016.05.011","article-title":"Upregulation of haploinsufficient gene expression in the brain by targeting a long non-coding RNA improves seizure phenotype in a model of Dravet syndrome","volume":"9","author":"Hsiao","year":"2016","journal-title":"EBioMedicine"},{"key":"R54-20260427","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1590\/s1679-45082017rb4024","article-title":"Gene therapy: Advances, challenges and perspectives","volume":"15","author":"Gon\u00e7alves","year":"2017","journal-title":"Einstein (S\u00e3o Paulo)"},{"key":"R55-20260427","doi-asserted-by":"crossref","first-page":"108741","DOI":"10.1016\/j.yebeh.2022.108741","article-title":"Genetic therapeutic advancements for Dravet Syndrome","volume":"132","author":"Chilcott","year":"2022","journal-title":"Epilepsy Behav"},{"key":"R56-20260427","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1089\/hum.2022.037","article-title":"Cell-selective adeno-associated virus-mediated SCN1A gene regulation therapy rescues mortality and seizure phenotypes in a Dravet syndrome mouse model and is well tolerated in nonhuman primates","volume":"33","author":"Tanenhaus","year":"2022","journal-title":"Hum Gene Ther"}],"container-title":["Annals of Indian Academy of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aian.aian_49_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:53:05Z","timestamp":1786647185000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aian.aian_49_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/aian.aian_49_24","relation":{},"ISSN":["0972-2327","1998-3549"],"issn-type":[{"value":"0972-2327","type":"print"},{"value":"1998-3549","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"2024-01-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}